Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • pharma-news

    pharma-news - Page 2

    Pfizer clinches coronavirus vaccine deal with German drugmaker, sees potential in antiviral treatment

    Pfizer clinches coronavirus vaccine deal with German drugmaker, sees potential in antiviral treatment

    Medical Dialogues Bureau12 April 2020 1:54 PM IST
    New York: U.S. drugmaker Pfizer Inc said on Thursday that early data has helped it identify a drug candidate with the potential to help treat patients...
    NPPA fixes prices of 29 formulations under DPCO, check out details

    NPPA fixes prices of 29 formulations under DPCO, check out details

    Medical Dialogues Bureau12 April 2020 1:37 PM IST
    Many of the drugs whose price has been fixed includes popular cardio-diabetes products, paracetemol combinations, and many more
    Bioheaven gets USFDA go ahead to begin phase 2 trial of intranasal vazegepant to treat lung inflammation after COVID-19 infection

    Bioheaven gets USFDA go ahead to begin phase 2 trial of intranasal vazegepant to treat lung inflammation after COVID-19 infection

    Medical Dialogues Bureau12 April 2020 1:30 PM IST
    Vazegepant is currently advancing to Phase 3 development for the acute treatment of migraines in adults under the Division of Neurology, having...
    GSK , Vir Biotechnology enter collaboration to find coronavirus solutions

    GSK , Vir Biotechnology enter collaboration to find coronavirus solutions

    Medical Dialogues Bureau12 April 2020 10:45 AM IST
    London, UK and San Francisco, US: GlaxoSmithKline plc and Vir Biotechnology, Inc. have announced that they have signed a binding agreement to enter...
    India should become self-reliant in medical equipment, devices: Kasturirangan

    India should become self-reliant in medical equipment, devices: Kasturirangan

    Medical Dialogues Bureau12 April 2020 9:00 AM IST
    Bengaluru: India needs to come out with a policy to make the country self-reliant in the field of medical equipment and devices drawing lessons from...
    Cancer tech Patent Infringment: Gilead Sciences told to pay 1.2 billion dollars to Bristol-Myers Squibb

    Cancer tech Patent Infringment: Gilead Sciences told to pay 1.2 billion dollars to Bristol-Myers Squibb

    Medical Dialogues Bureau11 April 2020 1:56 PM IST
    USA: A federal judge increased to $1.2 billion the damages that Gilead Sciences Inc must pay to Bristol-Myers Squibb Co in a patent infringement...
    Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by manufacturers

    Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by manufacturers

    Medical Dialogues Bureau11 April 2020 1:18 PM IST
    New Delhi: With a recent notification, the Central Government has given powers to the National Pharmaceutical Pricing Authority (NPPA) under the...
    Zydus gets USFDA tentative nod for Empagliflozin Tablets

    Zydus gets USFDA tentative nod for Empagliflozin Tablets

    Medical Dialogues Bureau11 April 2020 12:17 PM IST
    Ahmedabad: Zydus Cadila has received tentative approval from the USFDA to market Empagliflozin Tablets, in the strengths of 10 mg and 25 mg (US RLD:...
    Dr Reddys Labs receives EIR for Nalgonda-based API plant

    Dr Reddy's Labs receives EIR for Nalgonda-based API plant

    Medical Dialogues Bureau11 April 2020 11:03 AM IST
    New Delhi: Dr Reddy's Laboratories has announced that it has received an establishment inspection report (EIR) from the US health regulator for its...
    Sanofi to donate 100 million doses of hydroxychloroquine across 50 countries

    Sanofi to donate 100 million doses of hydroxychloroquine across 50 countries

    Medical Dialogues Bureau11 April 2020 9:30 AM IST
    Paris: French pharma major Sanofi said on Friday it has decided to donate 100 million doses of hydroxychloroquine, the anti-malaria drug which could...
    Centre steps up efforts to ensure availability of medical oxygen

    Centre steps up efforts to ensure availability of medical oxygen

    Medical Dialogues Bureau11 April 2020 9:00 AM IST
    Thiruvananthapuram: After seeing several countries facing problem due to lack of medical oxygen, the Indian government is making all possible efforts...
    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    Medical Dialogues Bureau10 April 2020 1:00 PM IST
    Hyderabad: Aurobindo Pharma Limited has announced that the Company has received the final approval from the US Food & Drug Administration (USFDA)...
    PrevNext

    Popular Stories

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Aurobindo Pharma faces CA Suit in US for concealing facts

    Aurobindo Pharma faces CA Suit in US for concealing facts

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    Cygnus Medicare sells majority stake to Amar Ujala for Rs 130 crore

    Cygnus Medicare sells majority stake to Amar Ujala for Rs 130 crore

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by manufacturers

    Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by...

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok